KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Receivables - Other (2018 - 2025)

Twist Bioscience (TWST) has disclosed Receivables - Other for 6 consecutive years, with $5.6 million as the latest value for Q2 2023.

  • On a quarterly basis, Receivables - Other rose 17.04% to $5.6 million in Q2 2023 year-over-year; TTM through Jun 2023 was $5.6 million, a 17.04% increase, with the full-year FY2022 number at $4.8 million, up 106.33% from a year prior.
  • Receivables - Other was $5.6 million for Q2 2023 at Twist Bioscience, up from $5.3 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $6.4 million in Q1 2022 to a low of $200000.0 in Q4 2022.
  • A 5-year average of $2.9 million and a median of $2.3 million in 2020 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: skyrocketed 1650.67% in 2019, then decreased 27.57% in 2020.
  • Twist Bioscience's Receivables - Other stood at $920000.0 in 2019, then skyrocketed by 145.65% to $2.3 million in 2020, then fell by 11.5% to $2.0 million in 2021, then tumbled by 90.0% to $200000.0 in 2022, then soared by 2684.5% to $5.6 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Receivables - Other are $5.6 million (Q2 2023), $5.3 million (Q1 2023), and $200000.0 (Q4 2022).